Drug target
Ribosomes, wall-building enzymes and gyrases are classic aims; a changed target may bind the drug less well.
Antibiotic resistance ? A shared drug budget under selection in hospitals, farms and wastewater — stewardship, not a lab manual.
A cell can alter a target, destroy a drug, pump it out, or block entry. Those are categories, not instructions.
Spread is often social: conjugation and other gene transfer move cassettes faster than waiting for a new mutation in every lineage.
Ribosomes, wall-building enzymes and gyrases are classic aims; a changed target may bind the drug less well.
Beta-lactamases cut penicillins and related drugs. Extended-spectrum and carbapenemase families widened the problem.
Membrane pumps lower the internal dose. They often move several chemical classes at once.
Gram-negative outer membranes can admit less drug when porin patterns shift.
Mobile DNA files resistance genes in stacks that can hop between cells.
Some cells survive a pulse without heritable resistance. That is a different, still conceptual, problem.
A drug reaches a community in a patient, animal or pipe.
Susceptible cells fall; already resistant or lucky mutants remain.
Plasmids and phages can move successful cassettes to new species.
A treatment that used to work fails more often; labs and policies notice.
No protocol for inducing resistance belongs on an encyclopedia page for the public.
Populations of genomes, not cartoon villains — RNA viruses copy sloppily, and public-health names track clusters that spread.
Familiarity 92Antibodies, memory cells and community arithmetic — conceptual, not a prescription and not an anti-vaccine tract.
Familiarity 94Surface cities of microbes — plaque and catheters explain persistence, without a grow-your-own kit.
Familiarity 38Clean water saves lives; missing old microbial partners is a separate, still-debated immune story.
Familiarity 70Sideways DNA traffic — conjugation, transduction, transformation as names and history, not protocols.
Familiarity 45